Ticker
TSHACompany Name
TAYSHA GENE THERAPIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 333.33M | $ 57.86M | 17.36% |
3/31/2025 | $ 138.36M | $ 59.55M | 43.04% |
12/31/2024 | $ 160.36M | $ 61.3M | 38.23% |
9/30/2024 | $ 180.22M | $ 60.72M | 33.69% |
6/30/2024 | $ 200.39M | $ 55.97M | 27.93% |
3/31/2024 | $ 153M | $ 59.01M | 38.57% |
12/31/2023 | $ 172.73M | $ 59.46M | 34.42% |
9/30/2023 | $ 195.77M | $ 57.65M | 29.45% |
6/30/2023 | $ 81.54M | $ 57.88M | 70.98% |
3/31/2023 | $ 101.6M | $ 58.09M | 57.17% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for TAYSHA GENE THERAPIES INC is calculated as follows: Debt [ $ 0 ] / Assets [ $ 279.27M ]
(=) Debt to Assets [ 0% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |